Are you attending #EASLCongress this week? Quantify’s Emilie Toresson Grip is on site and would be happy to connect!
Tomorrow, she will present the poster “Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden – a retrospective population-based […]
Studying rare diseases in real-world evidence often comes with challenges, such as lack of disease-specific diagnosis codes and complex definition of relevant endpoints. Over the years, Quantify has faced these challenges on […]
Denmark, through the Danish Medicines Council, will join FINOSE! We at Quantify foresee that this can potentially be a great preparation for both HTA bodies and pharmaceutical manufacturers for the upcoming EU HTA regulation. The addition of Denmark to FINOSE […]
The Quantify team has had a fantastic first day at #isporannual! Today’s schedule was full with many meetings and interesting program sessions.
One thing is clear – Nordic RWD has great […]
Will you be attending #ISPOR in #Boston next week? Quantify’s Kirk Geale, Emilie Toresson Grip & Puneet Kaushik will be on site and ready to connect at #ISPORAnnual! Keep a lookout for booth […]
The NPF has recently published a new strategy aiming to strengthen the collaboration between the Nordic countries. New, innovative and advanced therapies can offer hope and cure for patients, however it […]
Are you looking for a partner to provide support in Nordic HTA submissions? QUANTIFY is a true pan-Nordic vendor with hands-on expertise in all Nordic countries combined with experience developing Global HEOR material, in addition to local offices and in-house […]
Quantify Research will attend this year’s annual SHEA-conference (Swedish Health Economic Association) in Stockholm on Tuesday and Wednesday (April 25th-26th). Our Nordic HTA experts Lena Jacobs, Hannah Norman and Konstantin Macheridis will participate in this […]
We had a great time at the Nordic Rare Disease Summit 2023 last week, where important topics such as early diagnosis, patient empowerment, access to innovative treatments and EU legislation were discussed. […]
Today we are proud to introduce Greta Bütepage Uggla who will strengthen our Modelling, Access and Strategy team in Stockholm as Lead Analyst. Greta is specialized in health economics and data analytics, with experience in health economic modeling, data […]